Salveen Richter
Stock Analyst at Goldman Sachs
(4.49)
# 1,046
Out of 4,444 analysts
501
Total ratings
47.3%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Hold | $72 → $75 | $76.52 | -1.99% | 14 | Jun 24, 2026 | |
| QURE uniQure | Rated: Hold | $14 → $46 | $48.85 | -5.83% | 21 | Jun 17, 2026 | |
| MRNA Moderna | Maintained: Hold | $49 | $60.42 | -18.90% | 45 | Jun 16, 2026 | |
| INCY Incyte | Maintained: Hold | $98 → $100 | $108.46 | -7.80% | 24 | Jun 15, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Hold | $32 | $36.28 | -11.80% | 16 | Jun 14, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $9 | $15.50 | -41.94% | 17 | Jun 14, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $641 | $475.20 | +34.89% | 26 | Jun 10, 2026 | |
| APGE Apogee Therapeutics | Maintained: Hold | $89 | $132.69 | -32.93% | 2 | Jun 10, 2026 | |
| AMGN Amgen | Maintained: Buy | $425 → $389 | $351.43 | +10.69% | 20 | Jun 5, 2026 | |
| ELVN Enliven Therapeutics | Maintained: Buy | $59 | $47.77 | +23.51% | 5 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $18.02 | +22.09% | 11 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $23.37 | +75.44% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $968 | $623.43 | +55.27% | 23 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $238 → $250 | $199.59 | +25.26% | 30 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $19.75 | +77.22% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $7 | $5.30 | +32.08% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $127 → $69 | $57.33 | +20.36% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 | $125.16 | +3.87% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $11.62 | +183.99% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $15.93 | +0.44% | 2 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $14.25 | +187.72% | 3 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $549 → $550 | $294.06 | +87.04% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $34.22 | +46.11% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 | $40.00 | +27.50% | 2 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $26 | $16.23 | +60.20% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $61 → $25 | $29.11 | -14.12% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.94 | +58.50% | 5 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $16.70 | +1.83% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $28.80 | -44.44% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $17 | $23.36 | -27.23% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.80 | +75.93% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $48 | $53.55 | -10.36% | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $40 | $24.82 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.55 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $3.30 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $30 | $19.98 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $5 | $19.34 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $69.36 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $55.00 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $54.28 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $2.80 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $4.25 | $40.50 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $31 | $2.05 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $192.61 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.12 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $13.00 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $6.75 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $9 | $3.23 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $6 | $3.28 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $5.88 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $126 → $131 | $509.76 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $2.79 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $6.51 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $47 | $79.81 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $2 | $9.25 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $549.90 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $3.14 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.001 | n/a | 1 | Dec 2, 2011 |
Ionis Pharmaceuticals
Jun 24, 2026
Maintained: Hold
Price Target: $72 → $75
Current: $76.52
Upside: -1.99%
uniQure
Jun 17, 2026
Rated: Hold
Price Target: $14 → $46
Current: $48.85
Upside: -5.83%
Moderna
Jun 16, 2026
Maintained: Hold
Price Target: $49
Current: $60.42
Upside: -18.90%
Incyte
Jun 15, 2026
Maintained: Hold
Price Target: $98 → $100
Current: $108.46
Upside: -7.80%
Agios Pharmaceuticals
Jun 14, 2026
Maintained: Hold
Price Target: $32
Current: $36.28
Upside: -11.80%
Intellia Therapeutics
Jun 14, 2026
Maintained: Sell
Price Target: $9
Current: $15.50
Upside: -41.94%
Vertex Pharmaceuticals
Jun 10, 2026
Maintained: Buy
Price Target: $641
Current: $475.20
Upside: +34.89%
Apogee Therapeutics
Jun 10, 2026
Maintained: Hold
Price Target: $89
Current: $132.69
Upside: -32.93%
Amgen
Jun 5, 2026
Maintained: Buy
Price Target: $425 → $389
Current: $351.43
Upside: +10.69%
Enliven Therapeutics
Jun 4, 2026
Maintained: Buy
Price Target: $59
Current: $47.77
Upside: +23.51%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $18.02
Upside: +22.09%
Jun 1, 2026
Maintained: Buy
Price Target: $41
Current: $23.37
Upside: +75.44%
May 18, 2026
Maintained: Buy
Price Target: $968
Current: $623.43
Upside: +55.27%
May 15, 2026
Maintained: Buy
Price Target: $238 → $250
Current: $199.59
Upside: +25.26%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $19.75
Upside: +77.22%
May 12, 2026
Initiated Coverage: Hold
Price Target: $7
Current: $5.30
Upside: +32.08%
May 11, 2026
Initiated Coverage: Hold
Price Target: $127 → $69
Current: $57.33
Upside: +20.36%
May 8, 2026
Maintained: Hold
Price Target: $130
Current: $125.16
Upside: +3.87%
May 8, 2026
Maintained: Buy
Price Target: $38 → $33
Current: $11.62
Upside: +183.99%
May 4, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $15.93
Upside: +0.44%
May 1, 2026
Maintained: Buy
Price Target: $41
Current: $14.25
Upside: +187.72%
Apr 30, 2026
Maintained: Buy
Price Target: $549 → $550
Current: $294.06
Upside: +87.04%
Apr 30, 2026
Maintained: Buy
Price Target: $50
Current: $34.22
Upside: +46.11%
Apr 21, 2026
Maintained: Buy
Price Target: $51
Current: $40.00
Upside: +27.50%
Apr 9, 2026
Maintained: Buy
Price Target: $14 → $26
Current: $16.23
Upside: +60.20%
Mar 24, 2026
Downgraded: Hold
Price Target: $61 → $25
Current: $29.11
Upside: -14.12%
Mar 19, 2026
Maintained: Buy
Price Target: $11
Current: $6.94
Upside: +58.50%
Feb 25, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $16.70
Upside: +1.83%
Oct 30, 2025
Maintained: Hold
Price Target: $16
Current: $28.80
Upside: -44.44%
Aug 7, 2025
Maintained: Sell
Price Target: $15 → $17
Current: $23.36
Upside: -27.23%
Aug 7, 2025
Maintained: Hold
Price Target: $19
Current: $10.80
Upside: +75.93%
Aug 5, 2025
Maintained: Hold
Price Target: $47 → $48
Current: $53.55
Upside: -10.36%
Jan 28, 2025
Maintained: Buy
Price Target: $46 → $40
Current: $24.82
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $10.55
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $3.30
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $37 → $30
Current: $19.98
Upside: n/a
Feb 16, 2024
Maintained: Hold
Price Target: $48 → $5
Current: $19.34
Upside: n/a
Jan 8, 2024
Maintained: Buy
Price Target: n/a
Current: $69.36
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $55.00
Upside: n/a
Jul 31, 2023
Maintained: Buy
Price Target: $53
Current: $54.28
Upside: n/a
Jun 12, 2023
Maintained: Sell
Price Target: $7
Current: $2.80
Upside: n/a
May 15, 2023
Maintained: Hold
Price Target: $42 → $4.25
Current: $40.50
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $32 → $31
Current: $2.05
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $225
Current: $192.61
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.12
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $13.00
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $2 → $1
Current: $6.75
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $8 → $9
Current: $3.23
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $34 → $6
Current: $3.28
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $5.88
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $126 → $131
Current: $509.76
Upside: n/a
Nov 9, 2020
Maintained: Sell
Price Target: $11
Current: $2.79
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $6.51
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $45 → $47
Current: $79.81
Upside: n/a
Nov 13, 2019
Maintained: Sell
Price Target: $4 → $2
Current: $9.25
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $549.90
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $3.14
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.001
Upside: n/a